Position in IBRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$153,400
+$113,800 QoQ
Shares Held
20,000
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IBRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Ancora Advisors LLC holds $4,503,700 across 42 Biotechnology names. IBRX ranks #7 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | OMER |
Omeros Corp
|
115,000 | $1,214,400 | |
| 2 | GLSI |
Greenwich LifeSciences, Inc.
|
37,500 | $900,750 | |
| 3 | CRVS |
Corvus Pharmaceuticals, Inc.
|
54,768 | $801,255 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,050 | $468,867 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
4,016 | $191,041 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
2,391 | $179,540 | |
| 7 | IBRX |
ImmunityBio, Inc.
This page
|
20,000 | $153,400 | |
| 8 | SRPT |
Sarepta Therapeutics, Inc.
|
4,316 | $93,916 |
All Filings in IBRX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $153,400 | 20,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $39,600 | 20,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $24,600 | 10,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $26,400 | 10,000 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||